SC Filed 2019-08-29 Event — SEC 0001104659-19-047927 →

GILEAD SCIENCES INC → GALAPAGOS NV GLPGF

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

5 13D/G filings on this issuer

4 other filings besides this one

Filer Track Record

8 filings by this filer

7 other filings in the data moat

Short Interest · settle 2026-07-15

DTC 999.99

588,284 shares short · +16.1% vs prior

Institutional Consensus · 2026-03-31

Held by elite portfolio managers

3 holders · $36.99M

DME Capital ManagementGreenlight CapitalPoint72 Asset Mgmt

Other 13D/G Filings on GALAPAGOS NV

Filed	Form	Filer	Stake	Shares
2026-06-23	SCHEDULE 13G	Madison Avenue Partners, LP	—	—	view →
2025-05-19	SCHEDULE	EcoR1 Capital, LLC	11.84%	7,803,202	view →
2025-01-10	SCHEDULE	GILEAD SCIENCES, INC.	29.90%	20,981,010	view →
2024-10-08	SC	EcoR1 Capital, LLC	—	—	view →

Other Filings by GILEAD SCIENCES INC

Filed	Form	Issuer	Stake	Shares
2026-05-27	SCHEDULE 13D/A	ASSEMBLY BIOSCIENCES, INC. ASMB	25.10%	4,977,089	view →
2026-04-28	SCHEDULE 13D/A	Arcellx, Inc.	—	100	view →
2025-02-20	SCHEDULE	Arcus Biosciences, Inc. RCUS	35.00%	39,691,649	view →
2025-01-10	SCHEDULE	GALAPAGOS NV GLPGF	29.90%	20,981,010	view →
2024-06-20	SC	ASSEMBLY BIOSCIENCES, INC. ASMB	—	—	view →
2023-07-06	SC	Arcus Biosciences, Inc. RCUS	—	—	view →
2021-02-02	SC	Arcus Biosciences, Inc. RCUS	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →